ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Arch Biopartners Inc

Arch Biopartners Inc (ARCH)

1.95
-0.01
( -0.51% )
Updated: 11:34:11

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
1.95
Bid
1.96
Ask
1.97
Volume
1,200
1.95 Day's Range 1.96
0.00 52 Week Range 0.00
Market Cap
Previous Close
1.96
Open
1.96
Last Trade
100
@
1.95
Last Trade Time
09:55:45
Financial Volume
-
VWAP
-
Average Volume (3m)
-
Shares Outstanding
62,598,000
Dividend Yield
-
PE Ratio
-36.72
Earnings Per Share (EPS)
-0.05
Revenue
1.98M
Net Profit
-3.33M

About Arch Biopartners Inc

Sector
Coml Physical, Biologcl Resh
Industry
Advertising Agencies
Headquarters
Toronto, Ontario, Can
Founded
2010
Arch Biopartners Inc is listed in the Coml Physical, Biologcl Resh sector of the TSX Venture Exchange with ticker ARCH. The last closing price for Arch Biopartners was $1.96. Over the last year, Arch Biopartners shares have traded in a share price range of $ 0.00 to $ 0.00.

Arch Biopartners currently has 62,598,000 shares outstanding. The market capitalization of Arch Biopartners is $122.69 million. Arch Biopartners has a price to earnings ratio (PE ratio) of -36.72.

ARCH Latest News

Dosing of First Patient in a Trial for LSALT Peptide is Sending Shares HIgher

This late-stage clinical trial company focuses on preventing inflammation and acute organ injury. It is developing a platform of new drugs to prevent inflammation in the kidneys, liver and lungs...

Arch Biopartners Announces Dosing of First Patient in Canada in the Phase II Trial for LSALT Peptide Targeting Cardiac Surgery Associated-Acute Kidney Injury

TORONTO, Nov. 11, 2024 (GLOBE NEWSWIRE) -- Arch Biopartners Inc., (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF), announced today that patient recruitment and dosing have begun...

Arch Biopartners Arranges Non-Brokered Private Placement

TORONTO, Oct. 15, 2024 (GLOBE NEWSWIRE) -- Arch Biopartners Inc. (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF) today announced it has arranged a non-brokered private placement...

Closes Units for Debt Settlement

TORONTO, Oct. 03, 2024 (GLOBE NEWSWIRE) -- Arch Biopartners Inc., (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF) announced today that the Company has closed a transaction that...

Units for Debt Settlement

TORONTO, Sept. 26, 2024 (GLOBE NEWSWIRE) -- Arch Biopartners Inc. (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF) announced today that the Company has arranged a transaction to...

Arch Biopartners Announces Alberta Health Services Approval to Proceed with Phase II Trial for LSALT Peptide Targeting Cardiac Surgery-Associated Acute Kidney Injury (CS-AKI)

TORONTO, Sept. 11, 2024 (GLOBE NEWSWIRE) -- Arch Biopartners Inc., (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF), announced today that Alberta Health Services (AHS) has approved...

Arch Biopartners’ Cilastatin Drug Candidate to Participate in the PONTIAC Phase II Trial Targeting Acute Kidney Injury Caused by Drug Toxins

Arch is repurposing cilastatin, a dipeptidase-1 inhibitor, as a new treatment for acute kidney injury (AKI)Cilastatin is particularly well suited to prevent AKI caused by drug toxins due to its...

Arch Biopartners Closes Non-Brokered Private Placement

TORONTO, July 30, 2024 (GLOBE NEWSWIRE) -- Arch Biopartners Inc. (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF) today announced it has closed the non-brokered private placement...

Arch Biopartners Arranges Non-Brokered Private Placement

TORONTO, July 29, 2024 (GLOBE NEWSWIRE) -- Arch Biopartners Inc. (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF) today announced it has arranged a non-brokered private placement...

Arch Biopartners Announces GMP Manufacturing of Cilastatin Drug Product

TORONTO, June 27, 2024 (GLOBE NEWSWIRE) -- Arch Biopartners Inc., (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF), announced that Dalton Pharma Services (Dalton) has completed the...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
SCOTScottie Resources Corp
$ 0.99
(500.00%)
1.18k
SCLTSearchlight Resources Inc
$ 0.01
(100.00%)
32k
TVC.HThree Valley Copper Corp
$ 0.01
(100.00%)
1.5k
REEE Tech Resources Inc
$ 0.045
(80.00%)
5k
RYORio Silver Inc
$ 0.025
(66.67%)
19.54k
MAHMarksmen Energy Inc
$ 0.005
(-50.00%)
1.76M
VPIVitality Products Inc
$ 0.015
(-40.00%)
30k
GKOGeekco Technologies Corporation
$ 0.03
(-40.00%)
100k
VLXVelox Energy Materials Inc
$ 0.08
(-33.33%)
520
ALYAnalytixInsight Inc
$ 0.01
(-33.33%)
25k
ALALX Resources Corp
$ 0.03
(20.00%)
2.89M
QNCQuantum Emotion Corp
$ 0.195
(8.33%)
2.12M
MAHMarksmen Energy Inc
$ 0.005
(-50.00%)
1.76M
BARUBaru Gold Corp
$ 0.09
(28.57%)
1.69M
FUUF3 Uranium Corp
$ 0.255
(8.51%)
1.65M

Discussion

View Full Feed
learningcurve2020 learningcurve2020 2 minutes ago
We know where their true executional talent lies. 
NWBO
Screech691 Screech691 3 minutes ago
Nutrient-Rich Soil
The carefully crafted blend provides essential nutrients that promote deer health and vitality, ensuring a thriving population.
SGTM
Screech691 Screech691 3 minutes ago
Unmatched Attraction
Our powerful deer attractant acts as a magnet, drawing deer to your hunting plot like never before.
SGTM
Penny Stocks 2.0 Penny Stocks 2.0 3 minutes ago
$VTNRQ .0795 Exploding over $770,000,000 Assets// $2.4 Billion Sales
VTNRQ
Screech691 Screech691 3 minutes ago
The Ultimate Catnip for Deer
At SGTM, we are excited to unveil a groundbreaking product that is set to transform the world of deer hunting and wildlife observation.
SGTM
Penny Stocks 2.0 Penny Stocks 2.0 3 minutes ago
$VTNRQ .0795 Exploding over $770,000,000 Assets// $2.4 Billion Sales
VTNRQ
The Night Stalker The Night Stalker 3 minutes ago
NICE
OTLC
ducci1 ducci1 3 minutes ago
6060 ---Happy Face!---Good Call !!
SPY
Risk Risk 4 minutes ago
I totally agree OS. It's time for company to be transparent with the shareholders. Hopefully they realize soon the importance of communication. 
AFFU
Jetmek_03052 Jetmek_03052 4 minutes ago
Yup. You KEEP putting out BS. I agree.

The Company had developed new AI products which were described at the OTCM presentation and in the text of the 10-K and in the Update. Revenues to the consultancy are far higher than the previous commoditized services. DBMM will present revenue
DBMM OTCM
jbsliverer jbsliverer 4 minutes ago
https://bsky.app/profile/karenyourish.bsky.social/post/3lcfzltvcrs2v


.
HJ72 HJ72 4 minutes ago
https://www.otcmarkets.com/stock/AOXG/security
Ya never know, wish they'd file something .
AOXG
PickStocks PickStocks 4 minutes ago
Oh AZ...you are such a great investor with the help of your friends information.....you could not have done it without it.....your words....."sold 50.50 and coop no longer mattered until it broke 60 and beyond...". Laughing too hard side hurts.....
COOP
underpar71 underpar71 4 minutes ago
Generally, there is no specific, dedicated time frame outlined in the Federal Rules of Civil Procedure for a defendant to respond to a Notice of Supplemental Authority filing; however, most courts would expect a response within a reasonable time, often following the same timeframe as responding to o
NWBO
MrSmith101 MrSmith101 4 minutes ago
These morons declaes and pual suddenly want to be critical thinkers about trump…but blindly follow shawn leon and tell everyone “no one knows what leon is doing, but just trust him and you’ll be on the winning team”😂 oh how the irony is lost on them.
GRST
boston745 boston745 4 minutes ago
Tesla slams head-on into L.A. Metro bus in Rancho Park - Regular Driver

An investigation is underway after a Tesla crashed head-on into a Metro bus in the Rancho Park neighborhood of Los Angeles early Tuesday morning.

Video taken shortly after midnight showed both the T
TSLA
Humbert Humbert 5 minutes ago
No idea, but his presence doesn't change the intrinsic value of the stock. A lot of people are just waiting for audited financials, I think, and the uplist to OTCQB.
BNCM
Lone Clone Lone Clone 5 minutes ago
Global Uranium Engages Big Rock Exploration to Advance Wyoming Uranium Projects

Global Uranium is Leveraging Big Rock Exploration’s Expertise to Accelerate Drill Readiness and Target Refinement in Wyoming

https://www.globenewswire.com/news-release/2024/12/03/2990516/0/
Golden Cross Golden Cross 5 minutes ago
$ILLR ✨Triller, AGBA and #BKFC = Enormous Synergy and a Chance to Drive Major Business Growth! BKFC is the next UFC💫 Triller and Conor McGregor are both owners of BKFC 🚀
https://youtube.com/watch?v=0a12NVei5E0

[yt]0a12NVei5E0[/yt]
ILLR
ducci1 ducci1 5 minutes ago
ES 5 min Pivot & Red Line Retaken !! Quick Dip Maybe Thats It ?
SPY
Rambo Rell Rambo Rell 5 minutes ago
$ILLR With Sean Kim as CEO, Triller is more than a platform; it’s becoming an ecosystem for creators and brands. The market potential is immense, and $ILLR is on a fast track to global dominance. 📊 #SeanKim #FutureReady
ILLR
Rambo Rell Rambo Rell 5 minutes ago
$ILLR With Sean Kim as CEO, Triller is more than a platform; it’s becoming an ecosystem for creators and brands. The market potential is immense, and $ILLR is on a fast track to global dominance. 📊 #SeanKim #FutureReady
ILLR
blackhawks blackhawks 5 minutes ago
4 pages worth of search confirm wide media coverage; Fox is the unsurprising outlier.

https://www.google.com/search?newwindow=1&sca_esv=f29961f6c43f873e&rlz=1C1CHBF_enUS840US840&sxsrf=ADLYWIINMyX7h5StQCO_DAW1lkie9kLIXQ:1733248526048&q=Dinesh+D%27Souza+apologizes+for+false+claims+in+el
GetSeriousOK GetSeriousOK 5 minutes ago
Look, I realize you're all hyping the Koneru news because you have nothing else to hype.

but a change in the BOD at BIEL really isn't news. It means nothing. Koneru isn't going to do squat for BIEL other than fill the vacant seat to satisfy the Charter requirement and vote when they n
BIEL
Kool Aid Man Kool Aid Man 5 minutes ago
>IF< FY 2024 is audited it'll be March 2025 before it's due (90 days after Dec 31st). Auditing 2022-2023 antics by 'previous management' revealed little EXCEPT --for the first time-- the involvement of Epidemiologic Solutions Corp (ESC) 'charitable donations' to 'finance operations.'

SPZI